|
SV40 nucleic acid detection in human samples |
||||
| Country |
Positive reports on SV40 nucleic acids |
Negative reports on SV40 nucleic acids |
SV40 detection at 0% cut-off level |
SV40 detection at 10% cut-off level |
|
|
||||
| Austria |
[21,22] |
- |
- |
|
| Belgium |
[38,39] |
[40,41] |
+ |
+ |
| Finland |
[19,23] |
- |
- |
|
| France |
[42] |
[41,43] |
+ |
+ |
| Germany West |
[44-51] |
[52-54] |
+ |
+ |
| Germany East |
[55] |
+ |
+ |
|
| Hungary |
[51] |
+ |
+ |
|
| Italy |
[14,17,47,56-70]a |
[71-73] |
+ |
+ |
| Spain |
[74] low positive |
[71,75]b |
+ |
- |
| Sweden |
[76] |
+ |
+ |
|
| Switzerland |
[77] data also presented in [23] |
+ |
+ |
|
| Turkey |
[20,24] |
- |
- |
|
| United Kingdomc |
[78-81] |
[82-85] |
+ |
+ |
|
|
||||
| Total number of studies |
37 |
18 |
||
|
Percent cut-off level refers to percentage of SV40-positive human tissue samples in all samples tested in a country. aHealthy subjects were tested in [70]. bOne study [75] contained only uterine cervix carcinoma samples. cPleural cancer mortality data were available only for England and Scotland, but not for the entire U.K., therefore the U.K. was excluded from further statistical analysis. | ||||
Leithner et al. Orphanet Journal of Rare Diseases 2006 1:44 doi:10.1186/1750-1172-1-44 |
||||